Derailed endocytosis: an emerging feature of cancer

Abstract

Once engaged by soluble or matrix-anchored ligands, cell surface proteins are commonly sorted to lysosomal degradation through several endocytic pathways. Defective vesicular trafficking of growth factor receptors, as well as unbalanced recycling of integrin- and cadherin-based adhesion complexes, has emerged in the past 5 years as a multifaceted hallmark of malignant cells. In line with the cooperative nature of endocytic machineries, multiple oncogenic alterations underlie defective endocytosis, such as altered ubiquitylation (Cbl and Nedd4 ubiquitin ligases, for example), altered cytoskeletal interactions and alterations to Rab family members. Pharmaceutical interception of the propensity of tumour cells to derail their signalling and their adhesion receptors may constitute a novel target for cancer therapy.

DOI: 10.1038/nrc2521
0200400600200920102011201220132014201520162017
Citations per Year

2,970 Citations

Semantic Scholar estimates that this publication has 2,970 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Mosesson2008DerailedEA, title={Derailed endocytosis: an emerging feature of cancer}, author={Yaron Mosesson and Gordon B. Mills and Yosef Yarden}, journal={Nature Reviews Cancer}, year={2008}, volume={8}, pages={835-850} }